Literature DB >> 29406912

TNF-α -308 G/A and -238 G/A promoter polymorphisms and sporadic Parkinson's disease in an Italian cohort.

Cristina Agliardi1, Franca Rosa Guerini2, Milena Zanzottera2, Giulio Riboldazzi3, Roberta Zangaglia4, Giorgio Bono5, Carlo Casali6, Cherubino Di Lorenzo2, Claudio Pacchetti4, Raffaello Nemni7, Mario Clerici7.   

Abstract

The etiology of sporadic Parkinson's disease is (PD) still not understood but it is believed that a complex interplay between environmental and genetic factors could trigger the pathology. Pro-inflammatory TNF-α is released by activated microglia and is up-regulated in the brain and cerebrospinal fluid of PD patients; TNF-α modulates neuroinflammation and can activate the molecular mechanisms that lead to neurotoxicity and neuronal death. We analyzed two functional SNPs within the TNF-α gene promoter (rs361525 and rs1800629) in 354 Italian PD patients and 443 healthy controls (HC). In our cohort of patients, no significant associations could be observed between rs361525 and rs1800629 SNPs and either PD onset risk or PD-associated clinical parameters including age at onset of fluctuations, UPDRS-ME (Unified Parkinson Disease Rating Scale-Motor Examination), Schwab & England, Hohen & Yahr stage scale, and MMSE (Mini-Mental State Examination) score. Conflicting results on the role played by TNF-α rs1800629 SNP on PD onset risk are present in the literature. We could not find any association between TNF-α rs361525 and rs1800629 and PD.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; Polymorphism; SNP; TNF-α

Mesh:

Substances:

Year:  2017        PMID: 29406912     DOI: 10.1016/j.jns.2017.12.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: A case-control study and in silico analyses.

Authors:  Milad Heidari Nia; Mohsen Rokni; Shekoufeh Mirinejad; Maryam Kargar; Sara Rahdar; Saman Sargazi; Mohammad Sarhadi; Ramin Saravani
Journal:  J Med Virol       Date:  2021-12-02       Impact factor: 20.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.